This agreement enables TNIB to focus on the development and commercialization of therapeutic treatments for cancer, HIV/AIDS and autoimmune diseases by combating these fatal diseases through the activation and modulation of the body's immune system.
http://eon.businesswire.com/news/eon/20130911005268/en/TNI-BioTech-Signs-Manufacturing-Agreement-IRT-103-TM
http://eon.businesswire.com/news/eon/20130911005268/en/TNI-BioTech-Signs-Manufacturing-Agreement-IRT-103-TM
No comments:
Post a Comment